Ono Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Ono Pharmaceutical has a total shareholder equity of ¥788.1B and total debt of ¥150.0B, which brings its debt-to-equity ratio to 19%. Its total assets and total liabilities are ¥1,046.4B and ¥258.3B respectively. Ono Pharmaceutical's EBIT is ¥119.1B making its interest coverage ratio 2206.3. It has cash and short-term investments of ¥177.0B.
Key information
19.0%
Debt to equity ratio
JP¥150.00b
Debt
| Interest coverage ratio | 2206.3x |
| Cash | JP¥177.04b |
| Equity | JP¥788.11b |
| Total liabilities | JP¥258.30b |
| Total assets | JP¥1.05t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OPHL.Y's short term assets (¥401.4B) exceed its short term liabilities (¥124.7B).
Long Term Liabilities: OPHL.Y's short term assets (¥401.4B) exceed its long term liabilities (¥133.6B).
Debt to Equity History and Analysis
Debt Level: OPHL.Y has more cash than its total debt.
Reducing Debt: OPHL.Y's debt to equity ratio has increased from 0% to 19% over the past 5 years.
Debt Coverage: OPHL.Y's debt is well covered by operating cash flow (72.4%).
Interest Coverage: OPHL.Y's interest payments on its debt are well covered by EBIT (2206.3x coverage).